전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,045 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleEli Lilly and CompanyPhase 3

Mirikizumab (Mirikizumab)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Phase3#monoclonal-antibody#Eli
Trials 30Status Discontinued
AntibodyLimited DatastaleJohn ReneauPhase 1

Mogamulizumab (Mogamulizumab)

Recurrent Adult T-Cell Leukemia/Lymphoma; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma · Cutaneous T Cell Lymphoma

#CutaneousTCellLymphoma#Antibody#Phase1#monoclonal-antibody#RecurrentAdultT-CellLeukemia+3
Trials 30Status Recruiting
CGTLimited DatastaleBOE Technology Group Co., Ltd.Phase 2

NK cells + PD- (NK cells + PD-, NK cells + PD-(L)1 inhibitor + pemetrexed as first-line maintenance therapy)

NSCLC (Advanced Non-small Cell Lung Cancer); Colorectal Cancer · NSCLC (Advanced Non-small Cell Lung Canc

#NSCLCAdvancedNon-smallCellLungCa#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 30Status Recruiting
AntibodyLimited DatastaleRochePreclinical

trastuzumab (Herceptin, Pertuzumab Plus Trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#monoclonal-antibody#Roche
Trials 30Status Active
ADCLimited DatastaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab, trastuzumab-emtansine)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#ADC#Phase2#antibody-drug-conjugate#Roche
Trials 30Status Active
AntibodyLimited DatastaleRochePreclinical

trastuzumab (Herceptin, Pyrotinib Plus Trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#monoclonal-antibody#Roche
Trials 30Status Active
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Preclinical

T cell injection targeting CD19 chimeric antigen receptor (T cell injection targeting CD19 chimeric antigen receptor)

Systemic Lupus Erythematosus; Idiopathic Inflammatory Myopathies · CD19

#CD19#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 30Status Active
ADCLimited DatastaleRochePhase 2

ado-trastuzumab emtansine (Kadcyla, T-DM1, T-DM1 and Pertuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#antibody-drug-conjugate#BreastNeoplasms+2
Trials 30Status Recruiting
AntibodyLimited DatastaleTG Therapeutics, Inc.Phase 2

Ublituximab (Ublituximab)

Non-Hodgkins Lymphoma; B-cell Lymphoma · B-Cell Lymphoma

#B-CellLymphoma#Antibody#Phase2#monoclonal-antibody#Non-HodgkinsLymphoma+2
Trials 30Status Active
CGTLimited DatastaleKara Yakhteh Tajhiz Azma CompanyPhase 2

anti-CD19 CAR T cell therapy (anti-CD19 CAR T cell therapy)

Relapse/Refractory B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 30Status Recruiting
CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 1

anti-CD19 CAR-NK (anti-CD19 CAR-NK)

NHL · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 30Status Active
CGTLimited DatastaleHrain Biotechnology Co., Ltd.Preclinical

anti-CD19-CAR vector-transduced T cells (anti-CD19-CAR vector-transduced T cells)

Hematopoietic/Lymphoid Cancer; Adult Acute Lymphoblastic Leukemia in Remission · CD19

#CD19#CGT#Preclinical#cell-gene-therapy#CAR-T+5
Trials 30Status Active
CGTLimited DatastaleNanjing IASO Biotechnology Co.,…Preclinical

chimeric antigen receptor gene modified T cells (chimeric antigen receptor gene modified T cells)

Lymphoma, B-Cell · CD30

#CD30#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 30Status Recruiting
AntibodyLimited DatastaleJunshi BiosciencesPhase 2

humanized anti-PD-1 monoclonal antibody toripalimab (humanized anti-PD-1 monoclonal antibody toripalimab)

Advanced Melanoma; Metastatic Melanoma · PD-1

#PD-1#Antibody#Phase2#monoclonal-antibody#AdvancedMelanoma+2
Trials 30Status Active
CGTLimited DatastaleBeijing Bio-Targeting Therapeut…Phase 2

oncolytic virus (oncolytic virus)

Glioblastoma (GBM) · Glioblastoma (GBM)

#GlioblastomaGBM#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 30Status Recruiting
AntibodyLimited DatastaleJanssenApproved

teclistamab OR talquetamab OR elranatamab OR linvoseltamab (teclistamab OR talquetamab OR elranatamab OR linvoseltamab)

Waldenstrom Macroglobulinaemia; Multiple Myeloma · Waldenstrom Macroglobulinaemia

#WaldenstromMacroglobulinaemia#Antibody#Approved#monoclonal-antibody#MultipleMyeloma+1
Trials 30Status Recruiting
CGTLimited DatastaleGlycostem Therapeutics BVPhase 1

umbilical cord blood NK cells (umbilical cord blood NK cells)

Neuroblastoma · Soft Tissue Sarcoma (STS)

#SoftTissueSarcomaSTS#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 30Status Recruiting
AntibodyLimited DatastaleEli LillyPhase 2

Toripalimab + cetuximab (3cycles, 3cycles (Toripalimab + cetuximab))

Head and Neck Squamous Cell Carcinoma; Neoadjuvant Therapy · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase2#monoclonal-antibody#NeoadjuvantTherapy+1
Trials 29Status Recruiting
AntibodyLimited DatastaleAbbViePhase 3

Budigalimab (Budigalimab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase3#monoclonal-antibody#AbbVie
Trials 29Status Recruiting
AntibodyLimited DatastaleMarcela V. Maus, M.D.,Ph.D.Phase 2

Emapalumab (Emapalumab)

Large B-cell Lymphoma; Relapsed Non-Hodgkin Lymphoma · FRα

#FR#Antibody#Phase2#monoclonal-antibody#LargeB-cellLymphoma+2
Trials 29Status Recruiting

17 / 103 pages

← PreviousNext →